3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
15
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Carcinoma, Non-Small-Cell Lung
13
Multiple Myeloma
12
Lymphoma, Large B-Cell, Diffuse
11
Lymphoma
11
Hodgkin Disease
11
Lymphoma, Non-Hodgkin
10
Lymphoma, Follicular
8
Neoplasms
7
Lymphoma, Mantle-Cell
7
Leukemia, Lymphocytic, Chronic, B-Cell
7
Burkitt Lymphoma
7
Breast Neoplasms
7
Unspecified Adult Solid Tumor, Protocol Specific
6
Recurrence
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Neuroblastoma
6
Blast Crisis
6
Sezary Syndrome
5
Prostatic Neoplasms
5
Myeloproliferative Disorders
5
Myelodysplastic Syndromes
5
Mycosis Fungoides
5
Lymphoma, T-Cell, Cutaneous
5
Lymphoma, Large-Cell, Immunoblastic
5
Lymphoma, Large-Cell, Anaplastic
5
Lymphoma, Extranodal NK-T-Cell
5
Lymphoma, B-Cell, Marginal Zone
5
Brain Neoplasms
5
Interventions
Melphalan
4
Irinotecan
4
Filgrastim
4
Cyclophosphamide
4
Busulfan
4
fludarabine
3
Topotecan
3
Temozolomide
3
Granulocyte Colony-Stimulating Factor
3
pegfilgrastim
2
liposomal doxorubicin
2
Thiotepa
2
Sirolimus
2
Peripheral Blood Stem Cell Transplantation
2
Doxorubicin
2
Bone Marrow Transplantation
2
trioctyl phosphine oxide
1
ribociclib
1
regorafenib
1
poly ICLC
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
omburtamab I-131
1
olaparib
1
mocetinostat
1
lexatumumab
1
irinotecan sucrosofate
1
fludarabine phosphate
1
cixutumumab
1
ceritinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Rhabdomyosarcoma
×
Vorinostat
×
Clear all
NCT04308330
2026-04-15
NYMC195
New York Medical College
Phase 1
Recruiting
30 enrolled